ProfileGDS4718 / 238847_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 31% 58% 78% 43% 35% 58% 31% 48% 30% 33% 32% 40% 41% 21% 43% 59% 30% 36% 30% 33% 39% 33% 42% 34% 66% 40% 26% 89% 35% 38% 30% 45% 41% 36% 47% 19% 69% 45% 48% 38% 39% 35% 60% 68% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6050931
GSM549102patient 115, normal, homogenized [OPG study]6.0070158
GSM549104patient 119, normal, homogenized [OPG study]7.7219578
GSM549108patient 138, normal, homogenized [OPG study]5.2198343
GSM549119patient 077, normal, homogenized [OPG study]4.7783835
GSM549133patient 032, cancer, homogenized [OPG study]5.9480158
GSM549139patient 042, cancer, homogenized [OPG study]4.5762331
GSM549099patient 107, normal, homogenized [OPG study]5.423248
GSM549109patient 139, normal, homogenized [OPG study]4.5886430
GSM549110patient 046, normal, homogenized [OPG study]4.6769733
GSM549114patient 063, normal, homogenized [OPG study]4.5840932
GSM549122patient 082, normal, homogenized [OPG study]4.9846940
GSM549134patient 033, cancer, homogenized [OPG study]5.0237741
GSM549136patient 036, cancer, homogenized [OPG study]4.1317721
GSM549140patient 044, cancer, homogenized [OPG study]5.1143943
GSM549111patient 047, normal, homogenized [OPG study]6.0683859
GSM549113patient 057, normal, homogenized [OPG study]4.4711130
GSM549132patient 031, cancer, homogenized [OPG study]4.7939536
GSM549137patient 038, cancer, homogenized [OPG study]4.54230
GSM549142patient 047, cancer, homogenized [OPG study]4.7764533
GSM549100patient 110, normal, homogenized [OPG study]4.9894839
GSM549107patient 135, normal, homogenized [OPG study]4.6368233
GSM549115patient 068, normal, homogenized [OPG study]5.0264842
GSM549116patient 072, normal, homogenized [OPG study]4.6802734
GSM549120patient 078, normal, homogenized [OPG study]6.5648366
GSM549131patient 030, cancer, homogenized [OPG study]4.9319340
GSM549118patient 074, normal, homogenized [OPG study]4.3810126
GSM549129patient 027, cancer, homogenized [OPG study]8.8647589
GSM549123patient 088, normal, homogenized [OPG study]4.7476135
GSM549124patient 006, cancer, homogenized [OPG study]4.9516338
GSM549126patient 015, cancer, homogenized [OPG study]4.5318930
GSM549128patient 025, cancer, homogenized [OPG study]5.2489845
GSM549103patient 117, normal, homogenized [OPG study]5.0827341
GSM549117patient 073, normal, homogenized [OPG study]4.7589536
GSM549138patient 041, cancer, homogenized [OPG study]5.3308747
GSM549141patient 045, cancer, homogenized [OPG study]4.0484519
GSM549130patient 028, cancer, homogenized [OPG study]6.7670769
GSM549101patient 111, normal, homogenized [OPG study]5.2951845
GSM549105patient 128, normal, homogenized [OPG study]5.4158548
GSM549106patient 134, normal, homogenized [OPG study]4.8363238
GSM549112patient 048, normal, homogenized [OPG study]4.9259439
GSM549125patient 011, cancer, homogenized [OPG study]4.7622435
GSM549127patient 024, cancer, homogenized [OPG study]6.2063560
GSM549135patient 035, cancer, homogenized [OPG study]6.7156768